https://www.selleckchem.com/products/rp-3500.html
71, sensitivity = 64%, specificity = 80%, p = 0.009) and calprotectin 1.6 pg/mL allowed the identification of patients achieving negative CRP at T2 (AUC = 0.75, sensitivity = 74%, specificity = 76%, p less then 0.001) and patients with faecal calprotectin values less then 250 mg/kg at T2 (AUC = 0.71, sensitivity = 78%, specificity = 63%, p = 0.004). In conclusion, our study highlights a potential clinical role of serum cytokine levels for the prediction of clinical and biochemical steroid-free response in patients treated with vedolizum
Like
Comment
Share
